We examined the patient activation measure's (PAM's) association with process and health outcomes among adults with chronic conditions. Patients with high PAM scores were significantly more likely to perform self-management behaviors, use self-management services, and report high medication adherence, compared to patients with the lowest PAM scores. This population was 10 times more likely to report high patient-satisfaction scores, 5 times more likely to report high quality-of-life scores, and reported significantly higher physical and mental functional status scores, compared to those with the lowest scores. These results suggest that PAM scores are associated with key process and health outcome measures.
C
HRONIC disease reaps a considerable toll on the millions of patients who suffer with them (Wagner et al., 1996) . This is complicated by the fact that the prevalence of chronic conditions is increasing (Institue of Medicine [IOM], 2001) . This large increase in the prevalence of chronic conditions in the United States places unique demands on the healthcare delivery system (Renders et al., 2001 ). Unfortunately, medical professionals' attitudes were developed at a time predominated by acute, infectious diseases; these attitudes are simply not consistent with what is needed presently to man-age chronic conditions (Wagner et al., 1996) . Not only are chronic conditions different in their time course and severity, they also require the patient to make nearly continuous decision making owing to constantly changing circumstances (Holman & Lorig, 2000) . As a result, new patient-centered measures are needed to assess patients' abilities to manage chronic conditions. The Patient Activation Measure (PAM), developed by colleagues (2004, 2005) , is one such measure that deserves further investigation.
The PAM assesses a person's knowledge, skill, and confidence for managing one's own healthcare. This type of assessment is important because patients are more likely to make good decisions and promote their own health if they are more engaged, informed, and feel confident that they can take care of themselves (Lorig, 1996; Lorig et al., 1999; Von Korff et al., 1997 .
Assessment of patient activation using the PAM tool may also be important from a policy perspective. The recent Institute of Medicine Summit on Crossing the Quality Chasm suggested new directions in quality measurement, recommending that JOURNAL OF AMBULATORY CARE MANAGEMENT/JANUARY-MARCH 2007 measurement should focus on the patient and monitor their experiences (IOM, 2001) . The IOM recommended that such measurement should be integrated into the care delivery process and improve patient care. Such measurement should also be longitudinal and should capture patients' experiences over time. The PAM has the potential to meet these requirements and its use could further illuminate how chronic conditions affect this population (Hibbard et al., 2004) .
Previous research has found that the PAM is associated with improved outcomes. In a telephone survey of 1515 adults, Hibbard and colleagues (2004) found those with higher activation were more likely to exercise regularly, consume a low-fat diet, eat more fruits and vegetables, not smoke, and engage in consumerist health behaviors, such as finding a new provider's qualifications. No other research to date, however, has examined the PAM's association with comprehensive process measures and health-related outcomes. This article's primary objective is to examine the PAM's association with processand health-related outcomes for adults with chronic health conditions.
METHODS

Data source
In September 2004, we sent surveys to a random sample of Kaiser Permanente (KP) Medical Care program members from 1 of 6 chronic condition populations: (1) asthma, (2) diabetes (DM), (3) heart failure, (4) coronary artery disease (CAD), (5) chronic pain, and (6) both DM and CAD. The study sample was representative of KP's membership population and was selected from 7 of KP's 8 regions: Northern California, Southern California, Colorado, Georgia, Hawaii, Mid-Atlantic States, and Northwest. These regions represent about 90% of KP's total membership. We identified the study population from the Clinical Outcomes Research and Evaluation (CORE) database of the KP Care Management Institute. CORE identifies populations with chronic conditions on the basis of information from KP automated databases for pharmacy, inpatient and outpatient utilization, and laboratory use. Information from CORE is used to produce national evaluation reports (Kaiser Permanente Care Management Institute, 2003) and identify study populations that have been previously reported in peer-reviewed literature (Schatz et al., 2005a (Schatz et al., , 2005b . This population's overall physical and functional status is similar to that of other published research for populations with chronic conditions (Ware et al., 2001) .
We sent a total of 8908 surveys to the study population. Surveys were administered in English by mail and telephone. We first sent the survey by mail, and followed this with a telephone contact 3 weeks later for those that did not respond by mail. A total of 12 attempts were made to those administered the survey by telephone. We were able to reach 6673 respondents, yielding a contact rate of 75.4%. Reasons for no contact included incorrect addresses and phone numbers, participant was no longer a KP member, or the participant was not reachable.
Of the 6673 respondents contacted, 4108 completed the survey, for a total response rate of 61.2%. Respondents and nonrespondents did not differ on the basis of age, gender, and chronic condition (results not shown). The KP Northern California Institutional Review Board approved the study.
Survey elements
The cross-sectional survey included questions regarding age, sex, race/ethnicity, education (expressed as a 6-point scale from eighth grade or less to a postgraduate or professional degree), and self-reported height and weight (used to calculate body mass index). The 22-item Patient Activation Measure (PAM) was the primary independent variable used in the present analysis. The PAM was created using Rasch methodology and is a 1-dimensional, interval-level, Guttman-like scale (Hibbard et al., 2004) . The PAM has been extensively tested and shown to have strong psychometric properties (Hibbard et al., 2004) . It is measured on a theoretical 0 to 100 scale (0 = lowest activation, 100 = highest activation).
The study included 6 dependent variables: 3 process measures and 3 health-related outcome measures. The process measures included use of self-management services for chronic conditions, performance of selfmanagement behaviors, and medication adherence. Use of self-management services were assessed with a set of 5 "yes/no" questions asking whether the participant used common self-management services available 6 months prior to the interview. Selfmanagement services included use of the following: the Kaiser Permanente Web site, KP health education classes, KP HealthWise Handbook, KP HealthPhone (prerecorded health education audiotapes), and KP emotional support groups (specific questions listed in the Appendix). Performance of self-management behaviors included 4 items adapted from Hibbard and colleagues (2004) scored on a 4-point Likert-type scale (1 = strongly disagree, 2 = disagree, 3 = agree, 4 = strongly disagree) to create a self-management behavior index (Min = 4, Max = 16; Cronbach α = .63). Behaviors addressed included daily consumption of 5 servings of fruits and vegetables, performing tasks needed to manage chronic condition, following a regular exercise program, and following a regular stress management program (specific questions listed in the Appendix). Participants were asked how many days of medication doses were missed in the 7 days prior to interview to assess medication adherence (specific questions listed in the Appendix). We adapted this measure from an item developed by Chesney and colleagues as part of the Outcomes Committee of the Adults AIDS Clinical Trials (AACTG; Chesney et al., 2000; Wagner et al., 2001 ). Wagner and colleagues (2001) have validated Chesney's measure of self-reported medication adherence within an HIV population. Specifically, the measure was found to have high internal validity and be predictive of likely markers of nonadherence, such as decreased viral load, current alcohol use, current drug use, and depressive symptoms.
The health-related outcome measures included overall satisfaction with care, selfreported quality of life, and functional status.
Participants were asked to rate their overall satisfaction with the healthcare and services provided by Kaiser Permanente (0 = worst healthcare possible, 10 = best healthcare possible) in the year prior to their interview to assess satisfaction with care. This measure is currently used in the Consumer Assessment of Health Plans Survey (CAHPS) and has been reported elsewhere (CAHPS 2.0 Survey Reporting Kit, 2002) . We assessed quality of life by asking respondents to rate their overall quality of life on a 5-point scale (very good, good, neutral, poor, very poor). This item is currently used in the World Health Organization Quality of Life Brief Survey (WHOQOL-BREF) and has been reported elsewhere (WHOQOL Group, 1998) . We assessed functional status using the Short Form-8 (SF-8; Laliberte et al., 2002; Turner-Bowker et al., 2003; Ware et al., 2001) survey to produce the physical and mental component summary scores (PCS and MCS, respectively).
Statistical methods
Four of the 5 outcome measures were analyzed as a dichotomous measure: use of selfmanagement services (use of 1 or more services vs no use), high medication adherence (missed 1 or fewer medications vs 2 or more medications), high patient satisfaction (satisfaction score of 9 or higher vs 8 or lower; CAHPS Reporting Kit, 2002) , and high quality of life (very good/good vs neutral rating/poor/very poor). We analyzed functional status and the self-management performance index as a continuous measure. The PAM measure was analyzed using the 4 stages of activation: Stage 1-does not yet understand an active role is important (score ≤47.0); Stage 2-lacks knowledge and confidence to take action (score ≥47.1 and ≤55.1); Stage 3-beginning to take action (score ≥55.2 and ≤67.0); and Stage 4-maintaining behaviors over time (score ≥67.1). These cutpoints for the 4 stages of activation were empirically derived and were based on unpublished work by Hibbard and colleagues.
All analyses were performed using the Statistical Package for the Social Sciences (SPSS 13.0, SPSS Inc, Chicago Ill). We examined the 
RESULTS
Sample characteristics
Overall, the study population was older (mean age = 60 years), well educated (67% with some college or higher), evenly distributed among men and women, and represented a substantial nonwhite population (36%, Table 1 ). The sample was representative of Kaiser Permanente's population, with about two thirds of the sample being drawn from the Northern and Southern California Regions. The mean BMI was 29.4 and nearly 40% reported a BMI of 30 or higher, the recognized BMI marker for obesity.
The mean PAM score for the population was 56.8 (Table 2 ). About 12% scored in the Activation Stage 1 range, nearly half scored in the Activation Stage 2 range, and just over one third scored in the Activation Stage 3 or higher. A majority of the study sample reported use of 1 or more self-management services (56.5%) and high medication adherence (90% reported 1 or fewer missed days of medications in the past 7 days). About half the study population reported high satisfaction with overall care and services from Kaiser Permanente (51.3% with satisfaction score ≥9) and high quality of life (nearly 70% reported "very good/good" quality of life).
Association of PAM with study outcome measures
PAM was significantly associated with all study outcomes in both bivariate and multivariable analysis (Tables 3-5) . Each increased stage of PAM scores was associated with improved outcomes for performance of self-management behaviors, medication adherence, satisfaction with services, self-reported quality of life, and functional status (Table 3) . Overall, higher PAM scores were associated with increased use of selfmanagement services, with the highest use of self-management services reported among those with Stage 3 PAM scores (Table 3) , with little difference reported between Stage 3 PAM and Stage 4 PAM scores. These results suggest that PAM is more sensitive in its ability to detect differences in 2 of the 3 process measures studied: performance of self-management behaviors and medication adherence, but less sensitive in its ability to detect differences in use of self-management services. With the exception of use of selfmanagement services, the greatest variation in study outcomes was reported between those with Stage 1 (lowest activation) and Stage 4 (highest activation) PAM scores. Compared with those with Stage 1 PAM scores, participants with Stage 4 PAM scores were nearly 3 times more likely to report high medication adherence, over 10 times more likely to report high patient-satisfaction scores, and about 5 times more likely to report high quality-of-life scores. Similarly, those with Stage 4 PAM scores reported 48% higher self-management behavior index scores and 26% and 29% higher PCS and MCS scores, respectively.
DISCUSSION
This study found that patient activation was independently associated with process measures and health outcome measures for an adult population with chronic conditions. Similar to Hibbard and colleagues (2004) , we found that higher patient activation was associated with process measures. Specifically, those with higher PAM scores were more likely to perform self-management behaviors, use self-management services, and report higher medication adherence. Of critical importance, this study was the first to find an independent association between patient activation and health-related outcome measures. Those with the higher PAM scores were significantly more likely to report higher patient satisfaction, higher quality-of-life scores, and higher physical and mental functional status, compared with those with lower PAM scores.
We found that those with the lowest PAM scores also reported extremely low PCS scores. In fact, those with the lowest PAM scores reported physical functional status scores over 2 standard deviations below US national norms. These results suggest that PAM may be useful in identifying groups with low physical functional status and in possible need of further care management follow-up. Further work is needed to determine the feasibility of the PAM tool to identify new patients in need of care management services and to determine which specific PAM items are most adaptable in the clinical care setting. Furthermore, we found that the lowest PAM scores were reported among older adults, those with less than a high school education, and those with CAD, identifying other possible target groups for intervention (results not shown).
This study had several limitations. First, it is difficult to ascertain causality because of the cross-sectional study design. While Reference group: quality of life rated as "neither poor nor good" or "fair" or "poor."
higher PAM scores are associated with improved process measures, such as use of selfmanagement services, it is not clear whether increased patient activation leads patients to engage in more self-management, or whether the process of engaging in self-management activities increases patient activation. It is also not clear whether improved health outcome measures are due to higher PAM scores, or whether the study population had higher levels of PAM scores because of better a priori health status. The link between PAM and these process and outcome measures, however, strengthens the case for the PAM's potential use as the type of patient-focused quality measures recommended by the IOM. While respondents versus nonrespondents in this population were similar, and we garnered a robust response rate, this study did not measure PAM scores in the general KP population without chronic conditions; thus, results are not completely generalizable to the entire KP population.
Finally, this study was set in a large group model integrated delivery system. It is possible that results are not generalizable to patients with chronic conditions in other healthcare delivery systems where access to selfmanagement services and prescription medication differs from KP. The KP population, however, has been shown to be representative of the demographics within regions that it serves (Van Den Eeden et al., 2003) , which may increase the generalizability of these findings.
Further research is needed to examine the PAM's prospective effect on process level measures. Specifically, further investigation research is needed to examine the association of PAM with prospective changes in diseasespecific quality of care and utilization measures. Moreover, more work is needed to examine the impact of incremental changes in PAM scores on subsequent changes in key outcomes. Such information will be useful to national quality oversight organizations, such as the National Committee on Quality Assurance (NCQA), that are interested in identifying "patient-centered"quality of care measures associated with important outcome measures.
